Browsing Tag
Julie Sawyer Montgomery
1 post
Why does Danaher (DHR) completing the Masimo acquisition matter for diagnostics and patient monitoring?
Find out how Danaher’s $9.9bn Masimo acquisition could reshape DHR’s diagnostics growth, medtech competition and investor sentiment.